arrow_back Civic Audit
Share share

Workplace Safety: Training on Cannabis, Opioids, and Other Drugs

This act aims to enhance workplace safety by mandating research into educational programs. These programs will teach employers and workers how to prevent and respond to impairment related to cannabis, opioids, and other drug use. The act also provides for the development of a training program addressing the safety risks resulting from individuals working while impaired.
Key points
Research into educational programs for employees and employers on preventing and recognizing impairment from cannabis, opioids, and other drugs.
Development of a workplace training program on the impact of these substances on job safety.
Training will cover recognizing symptoms, responding to impairment, and guidance on company policies and relevant laws.
article Official text account_balance Process page notifications_active Track this Bill
gavel
Status:
Expired
Record your position for audit.
Why does your vote on bills matter?
It creates raw, undeniable proof. Civic Will provides the permanent data to verify the Government's loyalty towards its citizens (explained here). Start recording it now.
Additional Information
Print number: 117_HR_8591
Sponsor: Rep. Owens, Burgess [R-UT-4]
Process start date: 2022-07-29
System Note: Lustra is free, publicly auditable civic infrastructure, with full source code available on GitHub. You are reading sterilized legislative data, processed by our radical neutrality engine to strip political spin and retain factual mechanics. We process only official government data. Original documents remain the authoritative source, always verify them if you can.
Summarized by: gemini-3-pro-preview
Source data: api.congress.gov
AI work logs for this document launch

OFFICIAL LEGAL TITLE

To amend title III of the Public Health Service Act to direct the Secretary of Health and Human Services, acting through the Director of the National Institute for Occupational Safety and Health shall conduct research on programs to educate workplace professionals on the prevention of impairment from the use of cannabis, opioids, and other drugs, and the risks resulting from individuals working while impaired, and for other purposes.

FREQUENTLY ASKED QUESTIONS

What is the official ID of this bill?

The official print number for this legislation is 117_HR_8591.

Which chamber initiated this legislation?

This legislation was initiated in the House of Representatives.

When did the legislative process begin?

The process officially started on 2022-07-29.

What are the main provisions?

Key points include:

  • Research into educational programs for employees and employers on preventing and recognizing impairment from cannabis, opioids, and other drugs.
  • Development of a workplace training program on the impact of these substances on job safety.
  • Training will cover recognizing symptoms, responding to impairment, and guidance on company policies and relevant laws.
What is the specific legal status?

The current status is Expired.

Where can I read the full text of this legislation?

The full official text is available at: View full text

Who is the primary sponsor?

The primary sponsor is Rep. Owens, Burgess [R-UT-4].

What is the latest detailed status?

The latest detailed status is: Referred to the House Committee on Energy and Commerce.

Is this summary verified?

Yes. This content was analyzed by AI and verified by the Lustra Judge System on 2026-01-02.

What is the impact of this bill?

We don't know, that is up to you to decide. Summarizing raw data with AI is fundamentally different from predicting socio-economic outcomes. As of 2026, we believe impact assessment strictly requires a human in the loop to verify and judge.

CATEGORIES

Health Labor